Long-term response data for 255 patients with metastatic renal cell carcinoma treated with high-dose recombinant interleukin-2 therapy.
Fyfe
G A
GA
Fisher
R I
RI
Rosenberg
S A
SA
Sznol
M
M
Parkinson
D R
DR
Louie
A C
AC
D002292:Carcinoma, Renal Cell / Q000628:therapy*; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage*; D007680:Kidney Neoplasms / Q000628:therapy*; D011994:Recombinant Proteins / Q000008:administration & dosage; D012074:Remission Induction
D007376:Interleukin-2; D011994:Recombinant Proteins